{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=SGRQ", "query": { "intervention": "SGRQ" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=SGRQ&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-10T21:02:37.843Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06925295", "title": "Using Xe MRI to Guide Radiation Therapy for Lung Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Imaging Techniques" ], "interventions": [ { "name": "Xenon MRI", "type": "DRUG" }, { "name": "Pulmonary Function Testing", "type": "DIAGNOSTIC_TEST" }, { "name": "Quality of Life Questionnaire", "type": "OTHER" }, { "name": "Medical Research Council Dyspnea score", "type": "OTHER" }, { "name": "St. George's Respiratory Questionnaire", "type": "OTHER" }, { "name": "Blood Biomarkers", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Sean Fain", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 15, "start_date": "2025-08-30", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-01-02", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT06925295" }, { "nct_id": "NCT03002389", "title": "Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Anoro Ellipta", "type": "DRUG" }, { "name": "Arnuity Ellipta", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 95, "start_date": "2017-11-05", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2024-11-18", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 1, "location_summary": "Keswick, Virginia", "locations": [ { "city": "Keswick", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03002389" }, { "nct_id": "NCT03959982", "title": "HHHFA in COPD Patients, With Chronic Bronchitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "HHHFA Device", "type": "DEVICE" }, { "name": "Spirometry", "type": "DIAGNOSTIC_TEST" }, { "name": "6-minute walk", "type": "DIAGNOSTIC_TEST" }, { "name": "CT scan", "type": "DIAGNOSTIC_TEST" }, { "name": "Medical Research Council dyspnea scale (MRC)", "type": "OTHER" }, { "name": "St. George's Respiratory Questionnaire (SGRQ)", "type": "OTHER" }, { "name": "COPD Assessment Test (CAT)", "type": "OTHER" }, { "name": "Pittsburgh Sleep Quality Index (PSQI)", "type": "OTHER" }, { "name": "CASA-Q", "type": "OTHER" }, { "name": "Spirehealth Tag Device", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Spyridon Fortis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 11, "start_date": "2021-02-24", "completion_date": "2022-12-05", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03959982" }, { "nct_id": "NCT03034967", "title": "Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Danirixin", "type": "DRUG" }, { "name": "Danirixin matching placebo", "type": "DRUG" }, { "name": "Standard of care", "type": "DRUG" }, { "name": "Rescue medication", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 614, "start_date": "2017-04-25", "completion_date": "2018-10-05", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Topeka, Kansas • St Louis, Missouri + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Topeka", "state": "Kansas" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Greensboro", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03034967" }, { "nct_id": "NCT03121300", "title": "Functional Imaging in Lung SBRT", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "CT Scan", "type": "OTHER" }, { "name": "Lung CT", "type": "OTHER" }, { "name": "MRI", "type": "OTHER" }, { "name": "Walk Test", "type": "OTHER" }, { "name": "SGRQ", "type": "OTHER" }, { "name": "Biological Sample Collection", "type": "OTHER" }, { "name": "Toxicity", "type": "OTHER" }, { "name": "Cardiac Assessment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2017-02-06", "completion_date": "2019-08-30", "has_results": false, "last_update_posted_date": "2019-10-17", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03121300" }, { "nct_id": "NCT03269721", "title": "COPD-Related Physiology and the Brain", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive (COPD)", "Cognitive Impairment" ], "interventions": [ { "name": "Neuropsychological Assessment", "type": "BEHAVIORAL" }, { "name": "Spirometry", "type": "PROCEDURE" }, { "name": "Arterial Blood Gas", "type": "PROCEDURE" }, { "name": "Diffusion Capacity of the Lung for Carbon Monoxide", "type": "PROCEDURE" }, { "name": "6 Minute Walk Test", "type": "DIAGNOSTIC_TEST" }, { "name": "Systemic Vascular Measures", "type": "PROCEDURE" }, { "name": "Blood Biomarkers", "type": "BIOLOGICAL" }, { "name": "Symptom Questionnaire Measures", "type": "BEHAVIORAL" }, { "name": "Brain MRI", "type": "PROCEDURE" } ], "intervention_types": [ "BEHAVIORAL", "PROCEDURE", "DIAGNOSTIC_TEST", "BIOLOGICAL" ], "sponsor": "Karin Hoth", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "30 Years to 85 Years" }, "enrollment_count": 170, "start_date": "2017-05-01", "completion_date": "2025-04-30", "has_results": false, "last_update_posted_date": "2025-12-24", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03269721" }, { "nct_id": "NCT05074875", "title": "COVID-19 Respiratory Outcomes Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Covid19" ], "interventions": [ { "name": "Questionnaires and Patient Reported Outcomes (PROs)", "type": "OTHER" }, { "name": "Nasal Swab COVID-19 reverse transcription polymerase chain reaction test (RT-PCR)", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood Samples for Biomarkers", "type": "GENETIC" }, { "name": "High Resolution Computed Tomography", "type": "DIAGNOSTIC_TEST" }, { "name": "Physical Exam and Vital Signs", "type": "DIAGNOSTIC_TEST" }, { "name": "Medical Research Council Sum Score", "type": "DIAGNOSTIC_TEST" }, { "name": "Hand Grip Strength", "type": "DIAGNOSTIC_TEST" }, { "name": "Spirometry", "type": "DIAGNOSTIC_TEST" }, { "name": "Diffusing Capacity of Carbon Monoxide", "type": "DIAGNOSTIC_TEST" }, { "name": "6 Minute Walk Test", "type": "DIAGNOSTIC_TEST" }, { "name": "Sit to Stand (STS) Measurement", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST", "GENETIC" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2021-01-15", "completion_date": "2023-05-09", "has_results": false, "last_update_posted_date": "2023-07-27", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 4, "location_summary": "St Louis, Missouri • New York, New York • Houston, Texas", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05074875" }, { "nct_id": "NCT00259909", "title": "Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive", "Infections, Bacterial" ], "interventions": [ { "name": "GSK questionnaire", "type": "OTHER" }, { "name": "St. George's Respiratory Questionnaire", "type": "OTHER" }, { "name": "Acute Short Form 12 version 2", "type": "OTHER" }, { "name": "Global Efficacy questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 259, "start_date": "2005-11-02", "completion_date": "2006-11-07", "has_results": false, "last_update_posted_date": "2017-10-12", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 79, "location_summary": "Birmingham, Alabama • Hueytown, Alabama • Jasper, Alabama + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00259909" }, { "nct_id": "NCT02654145", "title": "Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Mepolizumab 100mg SC", "type": "DRUG" }, { "name": "Albuterol/salbutamol MDIs", "type": "DRUG" }, { "name": "Omalizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 145, "start_date": "2016-03-17", "completion_date": "2017-05-31", "has_results": true, "last_update_posted_date": "2019-08-19", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Riverside, California • Roseville, California + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Riverside", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02654145" }, { "nct_id": "NCT02152605", "title": "A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 498, "start_date": "2014-09-01", "completion_date": "2015-03-05", "has_results": true, "last_update_posted_date": "2017-11-09", "last_synced_at": "2026-09-10T21:02:37.843Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Upland, California • Clearwater, Florida + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Saint Charles", "state": "Missouri" }, { "city": "Anderson", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02152605" } ] }